These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6122858)

  • 1. Monoclonal antibodies in leukaemia and lymphoma.
    Lancet; 1982 May; 1(8280):1055-6. PubMed ID: 6122858
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
    Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF
    Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173
    [No Abstract]   [Full Text] [Related]  

  • 3. Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma.
    Waldmann TA
    Oncogene; 2007 May; 26(25):3699-703. PubMed ID: 17530023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of monoclonal antibodies in hematology].
    Pagnucco G; Bernasconi C
    Riv Emoter Immunoematol; 1984; 31(1):1-35. PubMed ID: 6085185
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis and classification of leukemia and malignant lymphoma cells using monoclonal antibodies].
    Uede T; Kikuchi K
    Nihon Rinsho; 1983; 41(4):815-20. PubMed ID: 6350650
    [No Abstract]   [Full Text] [Related]  

  • 6. T-lymphocyte malignancies: recent advances in the understanding of their biology, diagnosis and treatment.
    Parkinson DR; Mier JW
    Clin Immunol Rev; 1983; 2(1):59-121. PubMed ID: 6349892
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin receptors in lymphoid lesions. Relevance to diagnosis, biology, and therapy.
    Strauchen JA
    Pathol Annu; 1989; 24 Pt 2():149-65. PubMed ID: 2671880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phenotypic and functional characterization of malignant T-cell lymphoma].
    Naitoh H; Takesita M; Okamura H; Mitsui T; Tsutsui M; Kikuchi M
    Rinsho Ketsueki; 1986 Apr; 27(4):488-95. PubMed ID: 3488428
    [No Abstract]   [Full Text] [Related]  

  • 9. Dendritic cells, T-cells and their possible role in the treatment of leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2010 Apr; 42(2):189-92. PubMed ID: 20122870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivities of neoplastic T cells to human autoantibody and monoclonal antibodies.
    Takiuchi Y; Maruyama N; Hosokawa H; Horio S; Nasu K; Tatsumi E; Kita K; Shirakawa S; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):99-107. PubMed ID: 3873778
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of monoclonal antibodies. A new era in hematology].
    Obłakowski P
    Acta Haematol Pol; 1983; 14(3-4):219-27. PubMed ID: 6380186
    [No Abstract]   [Full Text] [Related]  

  • 12. [T-cell leukemia and lymphoma].
    Fenaux P; Jouet JP; Bauters F
    Rev Med Interne; 1987; 8(4):407-14. PubMed ID: 3501144
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical applications of monoclonal antibodies for patients with leukemia and lymphoma.
    Foon KA; Schroff RW; Bunn PA
    Prog Clin Biol Res; 1986; 211():265-84. PubMed ID: 3515361
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
    Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
    Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of membrane differentiation antigens and ATLA (adult T-cell leukemia virus-associated antigen) of 25 cultured cell lines derived from human T-cell leukemia/lymphoma].
    Tobinai K; Hoshino H; Miwa M; Nagai M; Setoya T; Shibata T; Minato K; Shimoyama M
    Nihon Ketsueki Gakkai Zasshi; 1984 May; 47(3):727-36. PubMed ID: 6089485
    [No Abstract]   [Full Text] [Related]  

  • 16. Hybridoma monoclonal antibody treatment of T-cell lymphomas: clinical experience and nursing management.
    DiJulio JE; Bedigian JS
    Oncol Nurs Forum; 1983; 10(2):22-27. PubMed ID: 6346276
    [No Abstract]   [Full Text] [Related]  

  • 17. CAR T cell therapy: inroads to response and resistance.
    Brown CE; Mackall CL
    Nat Rev Immunol; 2019 Feb; 19(2):73-74. PubMed ID: 30631206
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting malignant B cells of lymphoma and leukemia with genetically engineered T-cell clones.
    Jensen MC
    Cytotherapy; 2002; 4(5):443-4. PubMed ID: 12473219
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunopathology of lymphatic systemic diseases].
    Huber H; Gattringer C
    Wien Klin Wochenschr; 1983 May; 95(10):319-26. PubMed ID: 6351444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serotherapy of leukemia and lymphoma using monoclonal antibodies].
    Rupniewska ZM
    Pol Tyg Lek; 1985 Aug; 40(33):942-7. PubMed ID: 2997760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.